{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:16:23Z","timestamp":1775805383708,"version":"3.50.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["ECD.11486"],"award-info":[{"award-number":["ECD.11486"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["no 101003673"],"award-info":[{"award-number":["no 101003673"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Estimating COVID-19 vaccine effectiveness (VE) by time since vaccination (TSV) is essential for understanding how protection may change over time and enables meaningful comparisons across studies. This is important for accurate comparisons of VE against different SARS-CoV-2 variants\/sublineages, across age groups, during different periods post vaccination campaign, or by vaccine type\/brand. We provide recommendations for case\u2013control VE studies on estimating and reporting VE analyses by TSV, with the aim of improving quality of these estimates. Our recommendations cover study design and pre-analysis considerations, descriptive analyses, choice of categories of TSV, categorical and continuous modeling approaches, and best practices for reporting VE by TSV. Using a real-life case\u2013control study, we apply these recommendations and include accompanying statistical scripts in R and Stata. These recommendations will serve as a practical resource for researchers conducting VE analyses by TSV. We encourage ongoing refinement of them through input from other study groups.<\/jats:p>","DOI":"10.1093\/aje\/kwaf254","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T12:53:58Z","timestamp":1763211238000},"page":"1108-1119","source":"Crossref","is-referenced-by-count":0,"title":["Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study"],"prefix":"10.1093","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-8404","authenticated-orcid":false,"given":"Esther","family":"Kissling","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Epiconcept , Paris ,","place":["France"]},{"name":"Faculty of Medicine and Health Sciences, University of Antwerp , Antwerp ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6230-7209","authenticated-orcid":false,"given":"Baltazar","family":"Nunes","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Epiconcept , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-1740","authenticated-orcid":false,"given":"Mari\u00ebtte","family":"Hooiveld","sequence":"additional","affiliation":[{"name":"Nivel , Utrecht ,","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3405-2277","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Mart\u00ednez-Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra\u2014IdiSNA , Pamplona ,","place":["Spain"]},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-3012","authenticated-orcid":false,"given":"Susana","family":"Monge","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]},{"name":"National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII) , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-5241","authenticated-orcid":false,"given":"Chris","family":"Robertson","sequence":"additional","affiliation":[{"name":"Respiratory Team, Clinical and Protecting Health Directorate, Public Health Scotland , Glasgow ,","place":["United Kingdom"]},{"name":"Department of Mathematics and Statistics, Strathclyde University , Glasgow ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0645-5754","authenticated-orcid":false,"given":"Mirjam","family":"Knol","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM) , Bilthoven ,","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"S\u00e8ve","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Institut Pierre Louis d'\u00e9pid\u00e9miologie et de Sant\u00e9 Publique (IPLESP) , F75012, Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8546-6331","authenticated-orcid":false,"given":"Ivan","family":"Mlinari\u0107","sequence":"additional","affiliation":[{"name":"Division for Epidemiology of Communicable Diseases, Croatian Institute of Public Health , Zagreb ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-6703","authenticated-orcid":false,"given":"Lisa","family":"Domegan","sequence":"additional","affiliation":[{"name":"Health Service Executive-Health Protection Surveillance Centre , Dublin ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-1499","authenticated-orcid":false,"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[{"name":"Epidemiology Department, Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) , Lisbon ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5833-1863","authenticated-orcid":false,"given":"Heather","family":"Whitaker","sequence":"additional","affiliation":[{"name":"Statistics Unit, UK Health Security Agency , London ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8226-6026","authenticated-orcid":false,"given":"Mihaela","family":"Lazar","sequence":"additional","affiliation":[{"name":"National Influenza Centre, \"Cantacuzino\" National Military Medical Institute for Research and Development , Bucharest ,","place":["Romania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8074-7582","authenticated-orcid":false,"given":"Adam","family":"Meijer","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM) , Bilthoven ,","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-840X","authenticated-orcid":false,"given":"Theresa","family":"Enkirch","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The Public Health Agency of Sweden (Folkh\u00e4lsomyndigheten) , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6879-4984","authenticated-orcid":false,"given":"Itziar","family":"Casado","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra\u2014IdiSNA , Pamplona ,","place":["Spain"]},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-4854","authenticated-orcid":false,"given":"Gloria","family":"P\u00e9rez-Gimeno","sequence":"additional","affiliation":[{"name":"National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII) , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2267-677X","authenticated-orcid":false,"given":"Naoma","family":"William","sequence":"additional","affiliation":[{"name":"Respiratory Team, Clinical and Protecting Health Directorate, Public Health Scotland , Glasgow ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-4742","authenticated-orcid":false,"given":"Vincent","family":"Enouf","sequence":"additional","affiliation":[{"name":"Centre National de R\u00e9f\u00e9rence Virus des Infections Respiratoire, M3P Unit, Institut Pasteur Universit\u00e9 Paris Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-8174","authenticated-orcid":false,"given":"Sanja","family":"Kure\u010di\u0107 Filipovi\u0107","sequence":"additional","affiliation":[{"name":"Division for Epidemiology of Communicable Diseases, Croatian Institute of Public Health , Zagreb ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"McKenna","sequence":"additional","affiliation":[{"name":"Health Service Executive-Health Protection Surveillance Centre , Dublin ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2264-4723","authenticated-orcid":false,"given":"Ana Paula","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Epidemiology Department, Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) , Lisbon ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8553-2641","authenticated-orcid":false,"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford , Oxford ,","place":["United Kingdom"]},{"name":"Royal College of General Practitioners Research and Surveillance Centre , London ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia-Carmen","family":"Timnea","sequence":"additional","affiliation":[{"name":"National Influenza Centre, \"Cantacuzino\" National Military Medical Institute for Research and Development , Bucharest ,","place":["Romania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-2693","authenticated-orcid":false,"given":"Neus","family":"Latorre-Margalef","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The Public Health Agency of Sweden (Folkh\u00e4lsomyndigheten) , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-7265","authenticated-orcid":false,"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra\u2014IdiSNA , Pamplona ,","place":["Spain"]},{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-733X","authenticated-orcid":false,"given":"Francisco","family":"Pozo","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]},{"name":"National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII) , Madrid ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8806-2502","authenticated-orcid":false,"given":"Mark","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Respiratory Team, Clinical and Protecting Health Directorate, Public Health Scotland , Glasgow ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-4512","authenticated-orcid":false,"given":"Shirley","family":"Masse","sequence":"additional","affiliation":[{"name":"Unite des Virus Emergents (UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA) , Corsica ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7709-1797","authenticated-orcid":false,"given":"Maja","family":"Ili\u0107","sequence":"additional","affiliation":[{"name":"Division for Epidemiology of Communicable Diseases, Croatian Institute of Public Health , Zagreb ,","place":["Croatia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-2621","authenticated-orcid":false,"given":"Luca","family":"Basile","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) , Madrid ,","place":["Spain"]},{"name":"Subdirecci\u00f3n General de Vigilancia y Respuesta a Emergencias de Salud P\u00fablica, Agencia de Salud P\u00fablica , Catalunya ,","place":["Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"O\u2019Donnell","sequence":"additional","affiliation":[{"name":"Health Service Executive-Health Protection Surveillance Centre , Dublin ,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4563-6315","authenticated-orcid":false,"given":"Raquel","family":"Guiomar","sequence":"additional","affiliation":[{"name":"Reference Laboratory for Influenza and Other Respiratory Virus, Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge (INSA) , Lisbon ,","place":["Portugal"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5545-4825","authenticated-orcid":false,"given":"Maximilian","family":"Riess","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The Public Health Agency of Sweden (Folkh\u00e4lsomyndigheten) , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7354-9295","authenticated-orcid":false,"given":"Rodica-Manuela","family":"Popescu","sequence":"additional","affiliation":[{"name":"National Institute of Public Health, National Centre for Communicable Diseases Surveillance and Control , Bucharest ,","place":["Romania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-8082","authenticated-orcid":false,"given":"Angela M C","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Epiconcept , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-2684","authenticated-orcid":false,"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[{"name":"Statistics Unit, UK Health Security Agency , London ,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Bacci","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Pastore Celentano","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-1062","authenticated-orcid":false,"given":"Marta","family":"Valenciano","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Epiconcept , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Moren","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Epiconcept , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-3595","authenticated-orcid":false,"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[{"name":"Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp , Antwerp ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-0637","authenticated-orcid":false,"given":"Niel","family":"Hens","sequence":"additional","affiliation":[{"name":"Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp , Antwerp ,","place":["Belgium"]},{"name":"Data Science Institute, I-BioStat, Universiteit Hasselt , Hasselt ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of I-MOVE-COVID-19 and ECDC primary care study teams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"48","key":"2026041002364167400_ref1","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1016\/j.vaccine.2018.04.016","article-title":"A framework for research on vaccine effectiveness","volume":"36","author":"Crowcroft","year":"2018","journal-title":"Vaccine."},{"issue":"4","key":"2026041002364167400_ref2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/oxfordjournals.aje.a115884","article-title":"Direct and indirect effects in vaccine efficacy and effectiveness","volume":"133","author":"Halloran","year":"1991","journal-title":"Am J Epidemiol."},{"issue":"11","key":"2026041002364167400_ref3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"Klein","year":"2012","journal-title":"N Engl J Med."},{"issue":"10","key":"2026041002364167400_ref4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/oxfordjournals.aje.a009385","article-title":"Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines","volume":"147","author":"Durham","year":"1998","journal-title":"Am J Epidemiol."},{"issue":"5","key":"2026041002364167400_ref5","doi-asserted-by":"publisher","first-page":"20389","DOI":"10.2807\/ese.18.05.20389-en","article-title":"Vaccine effectiveness of 2011\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection","volume":"18","author":"Pebody","year":"2013","journal-title":"Euro Surveill."},{"issue":"5","key":"2026041002364167400_ref6","doi-asserted-by":"publisher","first-page":"20390","DOI":"10.2807\/ese.18.05.20390-en","article-title":"Low and decreasing vaccine effectiveness against influenza A(H3) in 2011\/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study","volume":"18","author":"Kissling","year":"2013","journal-title":"Euro Surveill."},{"issue":"10328","key":"2026041002364167400_ref7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet."},{"issue":"5","key":"2026041002364167400_ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.10650","article-title":"Evaluation of waning of SARS-CoV-2 vaccine\u2013induced immunity","volume":"6","author":"Menegale","year":"2023","journal-title":"JAMA Netw Open."},{"issue":"7","key":"2026041002364167400_ref9","doi-asserted-by":"publisher","first-page":"ofae370","DOI":"10.1093\/ofid\/ofae370","article-title":"Effectiveness of BNT162b2 XBB vaccine against XBB and JN.1 sublineages","volume":"11","author":"Tartof","year":"2024","journal-title":"Open Forum Infect Dis."},{"issue":"6","key":"2026041002364167400_ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325269","article-title":"Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up","volume":"20","author":"Carazo","year":"2025","journal-title":"PloS One."},{"issue":"1","key":"2026041002364167400_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106177","article-title":"Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study","volume":"89","author":"Kirsebom","year":"2024","journal-title":"J Infect."},{"issue":"15","key":"2026041002364167400_ref12","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1073\/pnas.0701396104","article-title":"Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution","volume":"104","author":"Shih","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"2026041002364167400_ref13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol."},{"issue":"6161","key":"2026041002364167400_ref14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"Koel","year":"2013","journal-title":"Science."},{"issue":"19","key":"2026041002364167400_ref15","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1016\/j.vaccine.2024.05.067","article-title":"Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023\u2013January 2024","volume":"42","author":"Laniece Delaunay","year":"2024","journal-title":"Vaccine."},{"issue":"8","key":"2026041002364167400_ref16","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13360","article-title":"Early COVID-19 XBB.1.5 vaccine effectiveness against hospitalisation among adults targeted for vaccination, VEBIS hospital network, Europe, October 2023\u2013January 2024","volume":"18","author":"Antunes","year":"2024","journal-title":"Influenza Resp Viruses."},{"issue":"4","key":"2026041002364167400_ref17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/infdis\/jiab480","article-title":"Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: a systematic review and meta-analysis","volume":"225","author":"Gao","year":"2022","journal-title":"J Infect Dis."},{"key":"2026041002364167400_ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1981","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ."},{"key":"2026041002364167400_ref19","author":"International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health"},{"issue":"6","key":"2026041002364167400_ref20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/EDE.0000000000001415","article-title":"Estimating vaccine efficacy against transmission via effect on viral load","volume":"32","author":"Kennedy-Shaffer","year":"2021","journal-title":"Epidemiology."},{"issue":"11","key":"2026041002364167400_ref21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis","volume":"53","author":"Sterne","year":"2000","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"2026041002364167400_ref22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2288-9-56","article-title":"Bias in odds ratios by logistic regression modelling and sample size","volume":"9","author":"Nemes","year":"2009","journal-title":"BMC Med Res Methodol."},{"issue":"1","key":"2026041002364167400_ref23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika."},{"issue":"12","key":"2026041002364167400_ref24","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol."},{"issue":"6","key":"2026041002364167400_ref25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol."},{"issue":"9","key":"2026041002364167400_ref26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jclinepi.2010.11.012","article-title":"Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure","volume":"64","author":"Courvoisier","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"none","key":"2026041002364167400_ref27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1214\/24-SS148","article-title":"A comprehensive review of bias reduction methods for logistic regression","volume":"18","author":"Stolte","year":"2024","journal-title":"Statist Surv."},{"issue":"4","key":"2026041002364167400_ref28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/00031305.2020.1731599","article-title":"Applications of the fractional-random-weight bootstrap","volume":"74","author":"Xu","year":"2020","journal-title":"Am Stat."},{"issue":"1","key":"2026041002364167400_ref29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12874-019-0666-3","article-title":"A review of spline function procedures in R","volume":"19","author":"Perperoglou","year":"2019","journal-title":"BMC Med Res Methodol."},{"issue":"8","key":"2026041002364167400_ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061126","article-title":"COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study","volume":"12","author":"Ostropolets","year":"2022","journal-title":"BMJ Open."},{"key":"2026041002364167400_ref31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2001"},{"key":"2026041002364167400_ref32","first-page":"488","volume-title":"Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach","author":"Burnham","year":"2010","edition":"2nd"},{"key":"2026041002364167400_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127567","article-title":"Analytical approaches and examples of addressing time-varying factors in COVID-19 vaccine effectiveness studies: report from a meeting of the World Health Organization","volume":"62","author":"Varma","year":"2025","journal-title":"Vaccine."},{"issue":"11","key":"2026041002364167400_ref34","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/aje\/kwaa084","article-title":"Temporal confounding in the test-negative design","volume":"189","author":"Dean","year":"2020","journal-title":"Am J Epidemiol."},{"issue":"2","key":"2026041002364167400_ref35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1536867X0900900204","article-title":"Two techniques for investigating interactions between treatment and continuous covariates in clinical trials","volume":"9","author":"Royston","year":"2009","journal-title":"Stata J."},{"key":"2026041002364167400_ref36","author":"Jr","year":"2024"},{"key":"2026041002364167400_ref37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1201\/9781315370279","volume-title":"Generalized Additive Models: An Isntroduction with R","author":"Wood","year":"2017","edition":"2nd"},{"key":"2026041002364167400_ref38","volume-title":"CRAN R Packages by Number of Downloads","author":"DataScienceMeta"},{"issue":"21","key":"2026041002364167400_ref39","doi-asserted-by":"publisher","first-page":"2101104","DOI":"10.2807\/1560-7917.ES.2022.27.21.2101104","article-title":"Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021","volume":"27","author":"Kissling","year":"2022","journal-title":"Eurosurveillance."},{"key":"2026041002364167400_ref40","author":"Epiconcept","year":"2021"},{"issue":"29","key":"2026041002364167400_ref41","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.29.2100670","article-title":"Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021","volume":"26","author":"Kissling","year":"2021","journal-title":"Eurosurveillance."},{"issue":"1","key":"2026041002364167400_ref42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/oxfordjournals.epirev.a017988","article-title":"Use of the case-control approach in vaccine evaluation: efficacy and adverse effects","volume":"21","author":"Rodrigues","year":"1999","journal-title":"Epidemiol Rev."},{"key":"2026041002364167400_ref43","volume-title":"R: A Language and Environment for Statistical Computing","author":"R core team"},{"key":"2026041002364167400_ref44","volume-title":"Stata Statistical Software","author":"StataCorp"},{"key":"2026041002364167400_ref45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-0-387-68636-3","volume-title":"Design and Analysis of Vaccine Studies","author":"Halloran","year":"2010"},{"issue":"458","key":"2026041002364167400_ref46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1198\/016214502760046943","article-title":"Estimation of waning vaccine efficacy","volume":"97","author":"Kanaan","year":"2002","journal-title":"J Am Stat Assoc."},{"issue":"12","key":"2026041002364167400_ref47","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/aje\/kwy163","article-title":"Measurement of vaccine direct effects under the test-negative design","volume":"187","author":"Lewnard","year":"2018","journal-title":"Am J Epidemiol."},{"key":"2026041002364167400_ref48","doi-asserted-by":"crossref","DOI":"10.4324\/9781315166414","volume-title":"Vaccination Programmes: Epidemiology, Monitoring, Evaluation","author":"Hahn\u00e9","year":"2021","edition":"1st"},{"issue":"2","key":"2026041002364167400_ref49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/QAD.0b013e32834e1ce7","article-title":"Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials","volume":"26","author":"O\u2019Hagan","year":"2012","journal-title":"AIDS."},{"issue":"6","key":"2026041002364167400_ref50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/aje\/kwad017","article-title":"Waning of 2-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection accounting for depletion-of-susceptibles bias","volume":"192","author":"Andrejko","year":"2023","journal-title":"Am J Epidemiol."},{"issue":"10","key":"2026041002364167400_ref51","doi-asserted-by":"publisher","first-page":"e633","DOI":"10.1093\/cid\/ciaa340","article-title":"Waning of measured influenza vaccine effectiveness over time: the potential contribution of leaky vaccine effect","volume":"71","author":"Tokars","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2026041002364167400_ref52","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/aje\/kwad191","article-title":"Examining bias from differential depletion of susceptibles in vaccine effectiveness estimates in settings of waning","volume":"193","author":"Kahn","year":"2024","journal-title":"Am J Epidemiol."},{"issue":"1","key":"2026041002364167400_ref53","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac698","article-title":"Absolute and relative vaccine effectiveness of primary and booster series of COVID-19 vaccines (mRNA and adenovirus vector) against COVID-19 hospitalizations in the United States, December 2021-April 2022","volume":"10","author":"Lewis","year":"2023","journal-title":"Open Forum Infect Dis."},{"issue":"10","key":"2026041002364167400_ref54","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med."},{"issue":"10","key":"2026041002364167400_ref55","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/cid\/ciy770","article-title":"Intraseason waning of influenza vaccine effectiveness","volume":"68","author":"Ray","year":"2019","journal-title":"Clin Infect Dis."},{"issue":"549","key":"2026041002364167400_ref56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/01621459.2024.2408776","article-title":"Quantification of vaccine waning as a challenge effect","volume":"120","author":"Janvin","year":"2025","journal-title":"J Am Stat Assoc."},{"issue":"5","key":"2026041002364167400_ref57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/infdis\/jix632","article-title":"Duration of influenza vaccine effectiveness: a systematic review, meta-analysis, and meta-regression of test-negative design case-control studies","volume":"217","author":"Young","year":"2018","journal-title":"J Infect Dis."}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwaf254\/65355090\/kwaf254.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/195\/4\/1108\/65355090\/kwaf254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/195\/4\/1108\/65355090\/kwaf254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:36:58Z","timestamp":1775803018000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/195\/4\/1108\/8325014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,17]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwaf254","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,11,17]]}}}